Ronen Borochovitz

Title: Ronen Borochovitz: Innovator in Pharmaceutical Processes

Introduction

Ronen Borochovitz is a notable inventor based in Netanya, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of clarithromycin polymorphs. His work has implications for the development of effective therapeutic agents.

Latest Patents

Ronen holds a patent for "Processes for preparing clarithromycin polymorphs and novel polymorph IV." This invention relates to processes for converting clarithromycin Form 0 to clarithromycin Form II, which includes slurrying clarithromycin Form 0 in water. The patent also covers the conversion of erythromycin A to clarithromycin and the subsequent transformation of clarithromycin Form 0 to Form II. Additionally, it introduces a novel clarithromycin polymorph Form IV, detailing its preparation, pharmaceutical compositions, and methods of use as a therapeutic agent. He has 1 patent to his name.

Career Highlights

Ronen is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative processes that enhance the efficacy of pharmaceutical compounds.

Collaborations

Throughout his career, Ronen has collaborated with talented professionals, including Ilya Avrutov and Igor Lifshitz. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Ronen Borochovitz is a distinguished inventor whose work in pharmaceutical processes has the potential to impact therapeutic applications significantly. His innovative approaches to clarithromycin polymorphs exemplify the importance of research and development in the pharmaceutical industry.